# Paul Harmatz, M.D. – FDA Inspection, Jun 16, 2017

Source: https://www.keypedia.com/records/fda_inspections/paul-harmatz-md/e5ba9ca4-8a82-49e6-b10f-e497c7f9f381
Source feed: FDA_Inspections

> FDA inspection 1014482 of Paul Harmatz, M.D., June 16, 2017. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 312. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1014482
- Company Name: Paul Harmatz, M.D.
- Inspection Date: 2017-06-16
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1280024 - 2025-08-21
- FDA Inspection 1131540 - 2020-11-05
- FDA Inspection 1131717 - 2020-10-16
- [FDA Inspection 849987 - 2013-10-02](https://www.keypedia.com/records/fda_inspections/paul-harmatz-md/78e94531-6e35-4dc4-9117-54234f582b4a)

## Related Officers

- Issuing Officer

Company: https://www.keypedia.com/companies/paul-harmatz-md/bcbc74e9-fa1d-4cbc-9de7-14e621beb38c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
